Administration of poly(I:C) protected mice showing increased survival of mice even with a challenge infection with a 10-fold-higher HSV2 load [56].In contrast, treatment with TLR4 or TLR2 ligands does not lead to a protective effect against a challenge infection with intravaginal HSV2 [57]. The gene discussed is TLR4; the disease is infection.